NewsBenzingaAllarity Therapeutics: EPS del terzo trimestre a $(0,39), inferiore alla stima di $(0,21); ricavi a $5,000K Allarity Therapeutics: EPS del terzo trimestre a $(0,39), inferiore alla stima di $(0,21); ricavi a $5,000K Benzinga 2026.11.13 13:09 (GMT+0) Open on Benzinga Other news Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says How to Play NKE Stock as Nike Risks Becoming a Forever Turnaround Story